Schedule 13G ownership disclosure
Processa Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 74275C106
Event date: 2020-10-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-20-006331
- Form type
- SC 13G
- Filer
- MANCHESTER MANAGEMENT CO LLC
- CIK
- CIK 1169253
- Filed
- Oct 13, 2020
- Reporting period
- Oct 02, 2020
- Description
- Schedule 13G beneficial ownership